Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 8
2012 5
2019 13
2020 60267
2021 86839
2022 56154
2023 28443
2024 7346

Text availability

Article attribute

Article type

Publication date

Search Results

213,134 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of SARS-CoV-2 and COVID-19.
Hu B, Guo H, Zhou P, Shi ZL. Hu B, et al. Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6. Nat Rev Microbiol. 2021. PMID: 33024307 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named 'coronavirus disease 2019' (COVID-19), whic …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that …
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. Gusev E, et al. Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716. Int J Mol Sci. 2022. PMID: 35163638 Free PMC article. Review.
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the …
The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus …
Structural biology of SARS-CoV-2 and implications for therapeutic development.
Yang H, Rao Z. Yang H, et al. Nat Rev Microbiol. 2021 Nov;19(11):685-700. doi: 10.1038/s41579-021-00630-8. Epub 2021 Sep 17. Nat Rev Microbiol. 2021. PMID: 34535791 Free PMC article. Review.
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis. ...The development of drugs that target vital proteins in the viral life cycle is a feasible approach for tr …
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unpr …
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.
To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. To KK, et al. Emerg Microbes Infect. 2021 Dec;10(1):507-535. doi: 10.1080/22221751.2021.1898291. Emerg Microbes Infect. 2021. PMID: 33666147 Free PMC article. Review.
Without modern medical management and vaccines, the severity of the Coronavirus Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) might approach the magnitude of 1894-plague (12 millio …
Without modern medical management and vaccines, the severity of the Coronavirus Disease 2019 (COVID-19) pandemic caused by sev …
SARS-CoV-2-specific virulence factors in COVID-19.
Kumar A, Prasoon P, Kumari C, Pareek V, Faiq MA, Narayan RK, Kulandhasamy M, Kant K. Kumar A, et al. J Med Virol. 2021 Mar;93(3):1343-1350. doi: 10.1002/jmv.26615. Epub 2020 Nov 1. J Med Virol. 2021. PMID: 33085084 Review.
The paucity of knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific virulence factors has greatly hampered the therapeutic management of patients with coronavirus disease 2019 (COVID-19). Recently, a cluster of s …
The paucity of knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific virulence factors …
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.
Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, Kastritis E, Pavlakis GN, Dimopoulos MA. Trougakos IP, et al. J Biomed Sci. 2021 Jan 12;28(1):9. doi: 10.1186/s12929-020-00703-5. J Biomed Sci. 2021. PMID: 33435929 Free PMC article. Review.
BACKGROUND: Gaining further insights into SARS-CoV-2 routes of infection and the underlying pathobiology of COVID-19 will support the design of rational treatments targeting the life cycle of the virus and/or the adverse effects (e.g., multi-org …
BACKGROUND: Gaining further insights into SARS-CoV-2 routes of infection and the underlying pathobiology of COVID …
The changing epidemiology of SARS-CoV-2.
Koelle K, Martin MA, Antia R, Lopman B, Dean NE. Koelle K, et al. Science. 2022 Mar 11;375(6585):1116-1121. doi: 10.1126/science.abm4915. Epub 2022 Mar 10. Science. 2022. PMID: 35271324 Free PMC article. Review.
We have come a long way since the start of the COVID-19 pandemic-from hoarding toilet paper and wiping down groceries to sending our children back to school and vaccinating billions. Over this period, the global community of epidemiologists and evolutionary biologis …
We have come a long way since the start of the COVID-19 pandemic-from hoarding toilet paper and wiping down groceries to sendi …
SARS-CoV-2: basic concepts, origin and treatment advances.
Santos-López G, Cortés-Hernández P, Vallejo-Ruiz V, Reyes-Leyva J. Santos-López G, et al. Gac Med Mex. 2021;157(1):84-89. doi: 10.24875/GMM.M21000524. Gac Med Mex. 2021. PMID: 34125824 Free article. Review. English.
The first cases of COVID-19, caused by the virus called SARS-CoV-2, were recorded in Wuhan, China, in December 2019; however, its transmission ability caused for the infection to be practically present throughout the world six months later. ...A …
The first cases of COVID-19, caused by the virus called SARS-CoV-2, were recorded in Wuhan, China, in Dec …
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.
Muralidar S, Ambi SV, Sekaran S, Krishnan UM. Muralidar S, et al. Biochimie. 2020 Dec;179:85-100. doi: 10.1016/j.biochi.2020.09.018. Epub 2020 Sep 22. Biochimie. 2020. PMID: 32971147 Free PMC article. Review.
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the globe causing serious concerns. ...There is no specific drug or vaccine targeting …
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that surfaced in …
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.
Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, Kumar A, Surani S. Ochani R, et al. Infez Med. 2021 Mar 1;29(1):20-36. Infez Med. 2021. PMID: 33664170 Free article. Review.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. ...SARS-CoV-2 transmission …
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, fi …
213,134 results
You have reached the last available page of results. Please see the User Guide for more information.